Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04879173Unknown

Clinical Value of Microvascular Ultrasonography in Real-time Differential Diagnosis of Thyrotoxic Patients

Role: lead

NCT02952612Unknown

Active Surveillance of Papillary Thyroid Microcarcinoma

Role: lead

NCT02462512Unknown

Diagnostic Performance of Ultrasound Elastography for Detection of Thyroid Cancer

Role: lead

All 3 trials loaded